Rights and permissions
About this article
Cite this article
Eptifibatide cost effective for acute coronary disorders. Inpharma Wkly. 1326, 5 (2002). https://doi.org/10.2165/00128413-200213260-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200213260-00010